Elevation of Dopamine D2 Receptors in Schizophrenia is Underestimated by Radioactive Raclopride
- 1 December 1990
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 47 (12) , 1170-2
- https://doi.org/10.1001/archpsyc.1990.01810240090014
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.Proceedings of the National Academy of Sciences, 1989
- Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: Implications for positron emission tomography of the human brainSynapse, 1989
- Human dopamine receptor subtypes?in vitro binding analysis using3H-SCH 23390 and3H-racloprideJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- Workshop on Schizophrenia, PET, and Dopamine D2 Receptors in the Human NeostriatumSchizophrenia Bulletin, 1988
- Human brain dopamine receptors in children and aging adultsSynapse, 1987
- Positron Emission Tomography Reveals Elevated D 2 Dopamine Receptors in Drug-Naive SchizophrenicsScience, 1986
- Bimodal Distribution of Dopamine Receptor Densities in Brains of SchizophrenicsScience, 1984